Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision

BACKGROUND: Hydroxyurea (HU) is underutilized in children with sickle cell disease (SCD) because caregivers frequently decline HU when it is offered. This study explores what impacts this decision. RESULTS: Caregivers of children with clinically severe SCD whose children were offered HU previously w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Res Notes
Asıl Yazarlar: Creary, Susan, Zickmund, Susan, Ross, Diana, Krishnamurti, Lakshmanan, Bogen, Debra L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Short Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4548690/
https://ncbi.nlm.nih.gov/pubmed/26303306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1344-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller